Ursodeoxycholic Acid + SilymarinThird Party Manufacturing in India

Ursodeoxycholic Acid + Silymarin works via a dual hepatoprotective action where ursodeoxycholic acid suppresses biliary cholesterol synthesis and reduces bile toxicity, while silymarin acts as an antioxidant and stabilizes hepatocyte membranes to block toxic influxes. This dual pathway accelerates protein synthesis for liver cell regeneration. Unlike single target therapies, it addresses the physiological mechanics of toxic bile accumulation and localized hepatic membrane damage simultaneously. It is highly effective and well-tolerated for chronic metabolic hepatic stress.

Therapeutic Uses

• Chronic Fatty Liver Disease: Management of non-alcoholic fatty liver disease (NAFLD) with elevated liver enzymes.
• Toxic Liver Damage: Supportive treatment for alcoholic or drug-induced hepatic degeneration.
• Advanced Cholestasis: Integrated protection against bile-duct inflammation and secondary hepatocellular injury.

Why Manufacturers Choose Ursodeoxycholic Acid + Silymarin

Ursodeoxycholic Acid + Silymarin third party manufacturing in India is a highly strategic addition for modern gastroenterology marketing franchises. Our partner facilities apply state of the art solid-dispersion techniques to handle the distinct dissolution rates of botanical silymarin extracts and bile acids. Celesta provides high compliance batches manufactured in WHO-GMP certified plants to give your brand a distinct competitive edge.